LAS VEGAS, NV / ACCESSWIRE / March 15, 2016 / We are issuing an immediate trade alert on Endonovo Therapeutics (OTCQB:ENDV) and a few other biotech companies.
ENDV has just crossed some major bullish indicators, and is on pace to cross more in the near term which should create an even larger demand for this stock that has recently made a 100% run, and closed Monday down 39%, which we see as a necessary consolidation, allowing a new batch of traders to take advantage of the bullish volatility of ENDV.
The 20 day, 50 day and 100 day Moving Averages are all bullish, the 20-100 day MACD oscillator is bullish as is the 50-100 day MACD oscillator. 50 day parabolic time/price is bullish, and the 60 commodity channel price index is bullish. With all these indicators pointing in the right direction for ENDV and a buy opportunity presenting itself after Monday's dip, it would make sense for investors to take a close look at entry on Tuesday.
Zynerba Pharmaceuticals, Inc. (ZYNE) had a huge breakout Monday up about 150%. This has set off several indicators including but not limited to the 20, 50 and 100 day moving averages and could bring a ton of interest into the stock over the next few sessions.
Vericel Corporation (VCEL) has had an incredible start to 2016, and there could be more to come.
Esperion Therapeutics, Inc. (ESPR) the company's stock is down about $3 from it's one month high of $18.32. Looking for a possible breakout to the recent high of $18.
Sangamo Biosciences Inc. (SGMO) after just recently breaking through it's 50 day moving average, this stock could be ready for a major breakout.
These stocks all look poised to perform for investors in the near term. ENDV looks to be at a particularly nice entry level, and we would suggest you start your own research immediately.
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. ACR Communication, LLC. which owns Microcapspeculators.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. ACR Communication, LLC., which owns Microcapspeculators.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. ACR Communication LLC., which owns Microcapspeculators.com, may be compensated for its services in the form of cash-based compensation or in equity in the companies it writes about, or a combination of the two. ACR Communication, LLC has been compensated a total of $18,000 cash by a non-affiliate third party of ENDV.
SOURCE: ACR Communication, LLC